11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - male - > 2,000 mg/kg (OECD Test Guideline 401)
Symptoms: Nausea
LC50 Inhalation - Rat - female - 4 h - 43.7 mg/l - vapour (OECD Test Guideline 403)
Symptoms: Possible damages:, mucosal irritations
LD50 Dermal - Rabbit - male and female - > 8,260 mg/kg (OECD Test Guideline 402)
Skin corrosion/irritation
Skin - Rabbit
Result: Irritating to skin. - 4 h (OECD Test Guideline 404)
Remarks: Drying-out effect resulting in rough and chapped skin.
Serious eye damage/eye irritation
Eyes - Rabbit
Result: Eye irritation
Remarks: (ECHA)
Respiratory or skin sensitization
Maximisation Test - Guinea pig
Result: negative (OECD Test Guideline 406)
Germ cell mutagenicity
May cause genetic defects.
Test Type: Ames test
Test system: Salmonella typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: Mutagenicity (mammal cell test): chromosome aberration.
Test system: Chinese hamster lung cells
Metabolic activation: with and without metabolic activation
Method: US-EPA
Result: positive
Test Type: Mutagenicity (mammal cell test): micronucleus.
Species: Mouse
Cell type: Bone marrow
Application Route: inhalation (vapour)
Method: OECD Test Guideline 474
Result: positive
Carcinogenicity
May cause cancer. Positive evidence from human epidemiological studies.
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Causes damage to organs through prolonged or repeated exposure.
- Blood
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
Aspiration hazard
Aspiration may cause pulmonary oedema and pneumonitis.
11.2 Additional Information
Repeated dose toxicity - Rat - male and female - Oral - 120 d - No observed ad- verse effect level - 100 mg/kg - Lowest observed adverse effect level - 25 mg/kg
Remarks: Subchronic toxicity
Systemic effects:
After absorption: agitation
Headache
Dizziness inebriation
Tiredness
CNS disorders narcosis respiratory arrest
Subacute toxicity
After a latency period:
Changes in the blood count haemolysis
Other dangerous properties can not be excluded.
This substance should be handled with particular care.